Study to Evaluate the Effectiveness of ABC+3TC +EFV in Once-Daily Regimens Versus KLT in Twice-Daily Regimens in Naive HIV Patients

NCT00318123 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

126

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Kivexa

Sponsor

Germans Trias i Pujol Hospital

Collaborators

[object Object]